APA (7th ed.) Citation

G, N., M, R., J, G., W, Z., B, T., SW, E., . . . R, G. (2021). Initial in vivo testing of TPO-receptor agonist eltrombopag in osteosarcoma patient-derived xenograft models by the pediatric preclinical testing consortium. Pediatric hematology and oncology, 38(1), 8. https://doi.org/10.1080/08880018.2020.1802539

Chicago Style (17th ed.) Citation

G, Nevil, et al. "Initial In vivo Testing of TPO-receptor Agonist Eltrombopag in Osteosarcoma Patient-derived Xenograft Models by the Pediatric Preclinical Testing Consortium." Pediatric Hematology and Oncology 38, no. 1 (2021): 8. https://doi.org/10.1080/08880018.2020.1802539.

MLA (9th ed.) Citation

G, Nevil, et al. "Initial In vivo Testing of TPO-receptor Agonist Eltrombopag in Osteosarcoma Patient-derived Xenograft Models by the Pediatric Preclinical Testing Consortium." Pediatric Hematology and Oncology, vol. 38, no. 1, 2021, p. 8, https://doi.org/10.1080/08880018.2020.1802539.